Rituximab-Induced Interstitial Lung Disease: A Possible Underestimated Complication-A Systematic Review. [PDF]
Zamfir AS +9 more
europepmc +1 more source
A 73‐Year‐Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping
ABSTRACT A 73‐year‐old man presented with progressive weakness and atrophy predominantly affecting the distal finger flexors and quadriceps muscles. Electrophysiological studies demonstrated mixed myogenic and neurogenic features. Muscle MRI showed inflammatory changes, and muscle biopsy revealed granulomatous myositis with histologic features ...
Mehmet Can Sari +3 more
wiley +1 more source
Survey of physicians' approaches to the clinical evaluation of interstitial lung disease in Singapore (SoPhoCLES). [PDF]
Teo FSW +16 more
europepmc +1 more source
Neuroinflammation in GAD65 Antibody‐Associated Epilepsy Measured Using [18F]DPA‐714 PET/MRI
ABSTRACT The timing for initiating immunotherapy in patients with glutamic acid decarboxylase 65 (GAD65) antibody‐associated epilepsy is a challenge. We used the translocator protein radioligand [18F]DPA‐714 and PET to evaluate brain microglial activation.
Jingjing Chen +10 more
wiley +1 more source
Factors associated with interstitial lung disease among patients with idiopathic inflammatory myopathies. [PDF]
Wilkerson JC +8 more
europepmc +1 more source
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley +1 more source
Interstitial Lung Disease in 2025-Progress, Challenges, and Hope Ahead. [PDF]
Sehgal S, Mehta A.
europepmc +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
ABPA in post-tuberculosis lung disease: A diagnostic pitfall or genuine entity? [PDF]
Sehgal IS, Muthu V, Agarwal R.
europepmc +1 more source
Lung surfactant kinetics for biomarker discovery in pulmonary disease [PDF]
Kewei Zhang
openalex

